多组学联合网络药理学揭示琥珀散治疗子宫内膜异位症大鼠的作用机制
该研究建立子宫内膜异位症(EMs)大鼠模型,评价琥珀散(HPS)疗效,并整合网络药理学、转录组学、非靶向代谢组学及体内实验验证其机制。结果显示HPS可减小异位病灶重量与体积,核心机制与Hippo信号通路激活相关,进而抑制增殖与血管生成、抑制炎症介质并恢复凋亡。
要点
- HPS可减小EMs大鼠异位病灶重量与体积。
- Hippo信号通路为HPS作用的关键通路,体内实验验证其被激活。
- HPS通过限增殖、抑血管生成、抗炎及恢复凋亡抑制病灶进展。
核心结论
- HPS可抑制EMs大鼠异位病灶生长,机制可能以调控Hippo信号通路为中心。
研究设计与样本
- 建立EMs大鼠模型评价HPS疗效,并联合网络药理学、转录组学、非靶向代谢组学及体内实验验证机制。
主要发现
- HPS降低EMs大鼠异位病灶重量与体积。
- 网络药理学与多组学分析一致提示Hippo信号通路为关键机制。
- 体内实验显示HPS激活Hippo通路,并逆转疾病相关异常:限制增殖与血管生成、抑制炎症介质、恢复凋亡。
临床怎么用
- 为HPS及其活性成分治疗EMs的后续开发提供了实验依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometriosis (EMs) is a persistent inflammatory condition whose three main symptoms, mass, pain, and infertility, severely affect female patients of childbearing age. Hu-Po-San (HPS), a preparation consisting of various herbal medicines, is clinically used to treat EMs with positive results; however, the underlying mechanism of HPS's efficacy in EMs is still unclear. OBJECTIVES: This study employed network pharmacology, transcriptomics, non-targeted metabolomics, and experimental validation to elucidate the mechanism of HPS in the treatment of EMs. METHODS: A rat model of EMs was established to evaluate the therapeutic efficacy of HPS. Network pharmacology integrated with multi-omics was used to predict potential mechanisms, which were verified in vivo. Molecular docking was performed to explore interactions between major HPS constituents and core pathway proteins. RESULTS: HPS decreased ectopic lesion weight and volume in rats with EMs. Network pharmacology integrated with multi-omics analyses consistently suggested the Hippo signaling pathway as a key mechanism; concordantly, HPS activated this pathway in vivo and reversed disease-associated abnormalities-limiting proliferation and angiogenesis, suppressing inflammatory mediators, and restoring apoptosis-thereby inhibiting lesion progression. CONCLUSION: HPS limits ectopic lesion growth in EMs rats, likely via modulation centered on Hippo signaling pathway. The current work offers fresh perspectives on the methodical application of traditional Chinese medicine (TCM) to the treatment of EMs in rats. It provides a basis for developing new therapeutic approaches for treating EMs with HPS and its active ingredients.
引用
- Huo C, Li F, Guo L, et al. Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology. Phytomedicine. 2025. PMID: 41197340. doi:10.1016/j.phymed.2025.157480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。